Autor: |
García-Montero, Cielo, Fraile-Martinez, Oscar, Cobo-Prieto, David, De Leon-Oliva, Diego, Boaru, Diego Liviu, De Castro-Martinez, Patricia, Pekarek, Leonel, Gragera, Raquel, Hernández-Fernández, Mauricio, Guijarro, Luis G., Toledo-Lobo, María Del Val, López-González, Laura, Díaz-Pedrero, Raul, Monserrat, Jorge, Álvarez-Mon, Melchor, Saez, Miguel A., Ortega, Miguel A. |
Předmět: |
|
Zdroj: |
Biomolecules (2218-273X); Aug2024, Vol. 14 Issue 8, p947, 30p |
Abstrakt: |
Pancreatic ductal adenocarcinoma (PDAC) is an extremely lethal tumor with increasing incidence, presenting numerous clinical challenges. The histopathological examination of novel, unexplored biomarkers offers a promising avenue for research, with significant translational potential for improving patient outcomes. In this study, we evaluated the prognostic significance of ferroptosis markers (TFRC, ALOX-5, ACSL-4, and GPX-4), circadian clock regulators (CLOCK, BMAL1, PER1, PER2), and KLOTHO in a retrospective cohort of 41 patients deceased by PDAC. Immunohistochemical techniques (IHC) and multiple statistical analyses (Kaplan–Meier curves, correlograms, and multinomial linear regression models) were performed. Our findings reveal that ferroptosis markers are directly associated with PDAC mortality, while circadian regulators and KLOTHO are inversely associated. Notably, TFRC emerged as the strongest risk marker associated with mortality (HR = 35.905), whereas CLOCK was identified as the most significant protective marker (HR = 0.01832). Correlation analyses indicate that ferroptosis markers are positively correlated with each other, as are circadian regulators, which also positively correlate with KLOTHO expression. In contrast, KLOTHO and circadian regulators exhibit inverse correlations with ferroptosis markers. Among the clinical variables examined, only the presence of chronic pathologies showed an association with the expression patterns of several proteins studied. These findings underscore the complexity of PDAC pathogenesis and highlight the need for further research into the specific molecular mechanisms driving disease progression. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|